TrialArthritis research & therapy2023

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.

Juergen Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.